Voyxact Patient Assistance Program

(sibeprenlimab-szsi)

Key Takeaways

  1. Voyxact (sibeprenlimab-szsi) is an APRIL blocker approved to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) who are at risk for disease progression. The indication received accelerated approval based on reduction in proteinuria.
  2. Voyxact blocks APRIL signaling, reducing levels of galactose-deficient IgA1 (Gd-IgA1), which is implicated in the development of IgAN. It is administered as a subcutaneous injection once every four weeks.
  3. Eligible patients may receive help accessing Voyxact through Prescription Hope. Assistance may help qualifying patients navigate medication access and treatment costs, with services available for $70.00 per month, per medication.

 

Introduction

Primary immunoglobulin A nephropathy can affect kidney health and may require ongoing treatment and monitoring. Voyxact provides a targeted treatment approach for adults with primary IgAN who are at risk for disease progression by reducing proteinuria, an important marker of kidney disease activity.

Voyxact is administered once every four weeks and may be self-administered or administered by a caregiver after appropriate training. For eligible patients who face challenges accessing their medication, Prescription Hope may help navigate prescription assistance and treatment costs.

What Is the Voyxact Patient Assistance Program

Some pharmaceutical manufacturers have come to recognize the financial strain caused by name-brand medication’s retail costs.

To help struggling Americans, pharmaceutical manufacturers sometimes launch something they call a patient assistance program, such as the Voyxact patient assistance program. These patient assistance programs allow qualified patients access to the name-brand medications they need at a lower cost than market rate.

However, patient assistance programs have a reputation for requiring extensive documentation and constant coordination with the patient’s healthcare provider and the pharmaceutical manufacturer. This can lead to confusion and frustration for those wishing to gain access to Voyxact medication.

But Prescription Hope is here to help.

How Expert Advocates Help Make Voyxact More Affordable

Personalized Medication Assistance

Prescription Hope’s Voyxact enrollment assistance allows qualified patients to gain access to their name-brand medication at a fraction of the retail cost. Our team of medication access advocates is specially trained to offer compassionate, personalized prescription assistance to obtain medication access. We help with any administrative needs through the process, including managing forms, documents, and signatures, communication with healthcare providers, coordination with manufacturers, and more.

Ongoing Patient Support

Our team of Voyxact patient advocates helps you apply for a patient assistance program. We also assist with administrative tasks after you are accepted. Our ongoing medication services include refill scheduling, document updates, yearly renewals, program monitoring, and more.

Voyxact Patient Assistance Eligibility

Patients interested in Voyxact medication access need to know the Voyxact patient assistance eligibility requirements. Patient assistance programs set qualification criteria ahead of time, but inquire through Prescription Hope to determine whether you qualify for Voyxact prescription assistance eligibility. Some categories that programs set requirements for are as follows:

Income: Each program sets its own criteria regarding a qualified income bracket.

Insurance: Each program also sets its own insurance coverage status.

Prescription: Patients must have a valid prescription for the name-brand medication they wish to apply for to qualify.

U.S. Residency: Patients must be legal U.S. citizens to qualify.

Simple Enrollment With Expert Support

Are you ready to get started with your Voyxact patient assistance application? Do you need help with your prescription assistance application? Prescription Hope’s medication assistance enrollment can be utilized in 6 easy steps:

  1. Submit Information: Take a few minutes to fill out our online application form.
  2. Advocate Contact: A patient advocate will contact you within 1-2 days after we receive your application form.
  3. Document Collection: After your prequalification phase, our team will collect any needed documents.
  4. Provider Coordination: Our team will also contact your healthcare provider for any needed signatures.
  5. Program Submission: After everything is in order, our team members will submit your application on your behalf. We will also continue to coordinate with the pharmaceutical manufacturer.
  6. Medication Delivery: After the program approval goes through, patients typically receive their medication in 2 weeks, shipped directly to their door or doctor’s office.

Understanding Voyxact

How Voyxact Works

Voyxact is an APRIL blocker. Sibeprenlimab-szsi binds to and blocks APRIL, preventing APRIL signaling through the BCMA and TACI receptors.

By blocking this signaling, it reduces serum levels of galactose-deficient IgA1 (Gd-IgA1), which is implicated in the pathogenesis of immunoglobulin A nephropathy.

What Conditions Does Voyxact Treat?

This medication is indicated to reduce proteinuria in adults with primary immunoglobulin A nephropathy who are at risk for disease progression.

The indication received accelerated approval based on reduction in proteinuria. It has not been established whether this medication slows long-term kidney function decline, and continued approval may depend on verification and description of clinical benefit in a confirmatory trial.

Benefits of Treatment

Voyxact reduces proteinuria, an important marker of kidney disease activity and a surrogate endpoint used in IgAN clinical trials.

Important Safety Information and Side Effects

Immunosuppression and Infections

Voyxact suppresses the immune system by reducing antibody production, which may increase the risk of infections. Patients should be assessed for active infections before treatment and monitored for signs and symptoms of infection. If a serious infection develops, treatment interruption should be considered until the infection is controlled.

Immunization Risks

This medication may interfere with immune responses to vaccines and increase the risk of infection from live vaccines. Live vaccines are not recommended within 30 days before starting treatment or during treatment.

Concomitant Immunosuppressants

Limited clinical data are available regarding use of Voyxact with systemic immunosuppressants. The potential for increased immunosuppression should be considered when these therapies are used together.

Hypersensitivity

Voyxact is contraindicated in patients with serious hypersensitivity to sibeprenlimab-szsi or any of its excipients.

Pregnancy

There are no available human data sufficient to evaluate the risk of major birth defects, miscarriage, or other adverse maternal or fetal outcomes. As with other monoclonal antibodies, sibeprenlimab-szsi may be transported across the placenta, with fetal exposure potentially increasing during the second and third trimesters.

In a monkey developmental study, no adverse embryofetal or postnatal effects were observed at exposures approximately 10 times the clinical exposure at the maximum recommended human dose.

Breastfeeding

There are no data on the presence of sibeprenlimab-szsi in human milk, its effects on a breastfed infant, or its effects on milk production. The benefits of breastfeeding should be considered alongside the mother’s clinical need for this medication and potential effects on the breastfed child.

Common Side Effects

The most common adverse reactions occurring in at least 10% of Voyxact-treated patients and at a higher incidence than placebo were infections, injection-site reactions, upper respiratory tract infection, and injection-site erythema. Most adverse reactions were mild or moderate and resolved without treatment interruption or discontinuation.

Access to Multiple Medications

Patients looking for specialty medication access are often looking for assistance for multiple prescriptions. Prescription Hope medication assistance offers qualified patients medication affordability support for hundreds of name-brand medications. This means that for every med you qualify for, Prescription Hope can offer help with your prescription assistance programs at the same low rate of $70.00 per month, per medication.

Why Choose Prescription Hope for Medication Assistance?

Patient-Focused Medication Support

For 20 years, Prescription Hope has offered personalized medication assistance to patients across America. Through Prescription Hope, Voyxact assistance allows patients access to the medication they need at a low cost.

Simplified Access to Specialty Therapies

Our service rate is as simple as $70.00 per month, per medication. With no add-ons, extra medication costs, or hidden fees. If Prescription Hope cannot help you save money, then you pay us nothing.

Ongoing Prescription Assistance

Voyxact patient support doesn’t just mean gaining access to the name-brand medication you need. We also offer qualified patients ongoing help with any administrative tasks needed to keep your IgA nephropathy medication assistance going. We offer long-term services, including refill scheduling, yearly renewals, document updates, program monitoring, and more.

Network Access

Prescription Hope’s network reaches across America, and we are here to help patients from rural areas to big cities gain access to the medication they need.

If you need Voyxact and can’t afford it, apply with Prescription Hope to see how we can help you save money today!

 

Frequently Asked Questions

It's Easy!

Submit Enrollment Form

Getting started is free and easy! Simply complete the online enrollment form. 

Receive Welcome Call

An Enrollment Specialist will reach out to you for a personalized welcome call.

We Manage The Process

Your dedicated team manages your account month after month, allowing you to focus on what matters most—your health.

Helpful Articles

Latest News & Stories

Save Money On Your Prescriptions Today!